2,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-thiazole
-1,3-thiazole.gif)
Product Information
Molecular Formula
C11H18BNO2S
Molecular Weight
239.14
Description
2,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-thiazole is a specialized chemical component used in drug discovery and development processes. It is important for the synthesis of bioactive compounds for various diseases such as cancer and viral infections.
Synonyms
2,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole; 2,4-DIMETHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,3-THIAZOLE; 2,4-Dimethylthiazole-5-boronic acid, pinacol ester; 2,4-dimethyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-thiazole; 2,4-Dimethylthiazole-5-boronic acid pinacol ester; 2,4-Dimethyl thiazole-5-boronic acid pinacol ester; 2,4-dimethyl-thiazole-5-boronic acid pinacol ester
IUPAC Name
2,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-thiazole
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=C(N=C(S2)C)C
InChI
InChI=1S/C11H18BNO2S/c1-7-9(16-8(2)13-7)12-14-10(3,4)11(5,6)15-12/h1-6H3
InChI Key
AZYDPQHPHNHZPL-UHFFFAOYSA-N
Flash Point
Not applicable
Safety Information
Hazards
H302 + H312 + H332 - H315 - H319
Precautionary Statement
P261 - P280 - P301 + P312 + P330 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
1
Exact Mass
239.1151302 g/mol
Monoisotopic Mass
239.1151302 g/mol
Topological Polar Surface Area
59.6Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
269
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021113263-A1 | Crf receptor antagonists and methods of use | 2019-12-04 |
| TW-202116311-A | Manufacturing method of insulin-producing cells using indoline derivatives | 2019-07-08 |
| CN-114040966-A | Method for producing insulin-producing cell using dihydroindolizinone derivative | 2019-07-08 |
| US-2021276996-A1 | Degraders that target proteins via keap1 | 2018-07-20 |
| TW-201938156-A | Dihydroporphyrinone derivatives | 2018-01-18 |
| CN-111630052-A | Dihydroindazinone derivatives | 2018-01-18 |
| EP-3741757-A1 | Dihydroindolizinone derivative | 2018-01-18 |
| IL-276125-D0 | Compounds derived from dihydroindolizinone, preparations containing them and their uses | 2018-01-18 |
| KR-20200110338-A | Dihydroindozinone derivatives | 2018-01-18 |
| US-2021053965-A1 | Dihydroindolizinone derivative | 2018-01-18 |
